NCT05986318 - Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 7, 2025

Primary Completion Date

July 1, 2028

Study Completion Date

December 31, 2032

Conditions

Lung CancerInterstitial Lung Disease

Interventions

DIETARY_SUPPLEMENT

N-Acetyl cysteine

NAC capsules

DRUG

Dexamethasone Oral

Dexamethasone tablets

DIETARY_SUPPLEMENT

N-Acetyl cysteine Placebo

Matching placebo for NAC capsules

DRUG

Dexamethasone Placebo

Matching placebo for dexamethasone tablets

RADIATION

Radiation Therapy

All participants will receive radical pulmonary radiation therapy. Conventional techniques or stereotactic ablative radiotherapy will be used.

Trial Locations (2)

RECRUITING

London Regional Cancer Program, London Health Sciences Centre, London

NOT_YET_RECRUITING

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal